Cervical Cancer Screening and Diagnosis — CPB 0443 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0443 covering cervical cancer screening and diagnosis, effective September 26, 2025. Here's what billing teams need to know before claims go out the door.

This update to the Aetna cervical cancer screening coverage policy touches 47 CPT codes, 13 HCPCS codes, and over 100 ICD-10-CM diagnosis codes. The split between covered and explicitly non-covered codes is sharp — and billing the wrong code means a denial. CPT 87624, 87625, and 87626 for HPV nucleic acid detection sit in the covered column. CPT 0096U and 0502U do not. That distinction alone will drive most of your claim denial risk under this policy.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Cervical Cancer Screening and Diagnosis
Policy Code	CPB 0443 Aetna
Change Type	Modified
Effective Date	September 26, 2025
Impact Level	High
Specialties Affected	OB/GYN, Women's Health, Family Medicine, Clinical Lab, Pathology
Key Action	Audit your charge capture for HPV testing codes and cytopathology before billing claims for dates of service on or after September 26, 2025

---

Aetna Cervical Cancer Screening Coverage Criteria and Medical Necessity Requirements 2025

The Aetna cervical cancer screening coverage policy under CPB 0443 covers a broad range of services — but only when specific selection criteria are met. That phrase "selection criteria" is doing a lot of work here. It means medical necessity drives every coverage decision on this policy. Billing without documentation that supports the clinical indication is how you lose reimbursement.

Covered services fall into three main categories: HPV nucleic acid detection, cytopathology screening, and pelvic examination. For HPV testing, CPT 87624 (high-risk HPV types), CPT 87625 (HPV types 16 and 18 only), and CPT 87626 (separately reported HPV types) are covered when selection criteria are met. The newer Category III code 0500T — covering detection of five or more HPV types — also sits in the covered column under the same conditions.

Cytopathology coverage is extensive. Codes 88141 through 88175 cover the full range of cervical and vaginal cytopathology methods, from manual screening to automated systems with physician supervision. On the HCPCS side, G0101 covers the pelvic and clinical breast examination as a screening service, and G0123 through G0148 cover the cytopathology smear methods under Medicare and Medicaid billing contexts.

Prior authorization requirements are not explicitly listed as a universal trigger in this policy summary, but that doesn't mean you skip the check. Prior auth requirements vary by plan and market. Confirm prior authorization requirements with the specific Aetna plan before scheduling high-cost molecular testing.

The ICD-10-CM diagnosis codes supporting coverage span cervical malignancies (C53.0–C53.x), HPV-related conditions (B97.7), HIV disease (B20), sexually transmitted infections (A50.01–A64), and a wide range of cervical abnormalities and follow-up diagnoses. Matching the right diagnosis code to the specific service is where medical necessity documentation either holds up or falls apart at audit.

---

Aetna Cervical Cancer Screening Exclusions and Non-Covered Indications

This is where the policy gets expensive if your team isn't paying attention. Several codes are explicitly not covered for indications listed in CPB 0443. These aren't gray areas — Aetna has drawn a hard line.

CPT 0096U and CPT 0502U are both proprietary lab analysis codes for HPV detection. Aetna does not cover these under this policy. If your lab is reporting HPV results using either of these codes on Aetna claims, expect denials. Swap to 87624 or 87625 where clinically appropriate and where those codes accurately describe the service performed.

CPT 57465 — computer-aided mapping of the cervix during colposcopy using optical dynamic spectral imaging — is not covered. This is a specific add-on technology that Aetna considers outside the scope of covered cervical cancer screening and diagnosis under this policy.

CPT 87623 for low-risk HPV types is not covered. High-risk HPV testing has a clear clinical rationale for cervical cancer screening. Low-risk HPV testing does not, and Aetna's position here aligns with most major payers and clinical guidelines.

The molecular cytogenetics codes — 88271 through 88275 and 88291 — are not covered under this policy. Neither are the in situ hybridization (FISH) codes: 88364 through 88377. This is a large block of codes (88364, 88365, 88366, 88367, 88368, 88369, 88370, 88371, 88372, 88373, 88374, 88375, 88376, 88377, 88291). If your pathology team is accustomed to billing these as add-ons to cervical cancer workups, flag this for your billing supervisor. These won't process under CPB 0443.

The real issue here is that some of these exclusions — particularly the FISH and molecular cytogenetics codes — might seem like natural extensions of cervical cancer diagnosis workup. They're not covered under this policy. Document that distinction in your internal billing guidelines now.

---

Coverage Indications at a Glance

---

Aetna Cervical Cancer Screening Billing Guidelines and Action Items 2025

Use these steps to get your team ready. The effective date is September 26, 2025 — that means claims for dates of service on or after that date fall under this version of the policy.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Cervical Cancer Screening Under CPB 0443

Covered CPT Codes (When Selection Criteria Are Met)

Covered HCPCS Codes (When Selection Criteria Are Met)

Not Covered CPT Codes

Key ICD-10-CM Diagnosis Codes

Note: The full ICD-10-CM code set under CPB 0443 includes 114 codes. The table above reflects the primary categories listed in the policy data. Review the full policy at Aetna CPB 0443 for the complete diagnosis code list before coding claims.

---